The Latest in T Cell Lymphomas

Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCL

December 9, 2019

HDAC/HMA combo shows ‘remarkable’ activity in PTCL

August 9, 2019

T Cell Lymphomas

Lymphoma risk prompts FDA recall of Allergan’s textured breast implants

July 24, 2019

T Cell Lymphomas

Creating CAR T-cell therapies for T-cell malignancies

April 16, 2019

Case report may link gluteal implants to lymphoma

March 12, 2019

T Cell Lymphomas

Alisertib response rate in PTCL patients was 33%

February 23, 2019

T Cell Lymphomas

Hidradenitis suppurativa linked to increased lymphoma risk

February 10, 2019

Increased risk of second cancers in mycosis fungoides

February 8, 2019

T Cell Lymphomas

FDA: 246 new reports on breast implant-associated lymphoma

February 7, 2019

T Cell Lymphomas

Cobomarsen shows early promise for treating ATLL

February 7, 2019

T Cell Lymphomas

Cerdulatinib yields ‘encouraging’ results in CTCL, PTCL

February 6, 2019

T Cell Lymphomas

Combo emerges as bridge to transplant in rel/ref PTCL

February 5, 2019

T Cell Lymphomas

Applying ECHELON-2 results to clinical practice

January 31, 2019

IPH4102 on fast track for Sézary syndrome

January 30, 2019

T Cell Lymphomas

Combo treatment may improve quality of life in CTCL

January 24, 2019